跳至主要内容
临床试验/NCT03779282
NCT03779282已完成不适用

KETODEX for Emergence Delirium in Children Undergoing Outpatient Strabismus Surgery

Ochsner Health System1 个研究点 分布在 1 个国家目标入组 90 人开始时间: 2018年2月15日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
90
试验地点
1
主要终点
Pediatric Anesthesia Emergence Delirium scale scores

研究概览

简要总结

Strabismus surgery for children is a very common procedure, with a high incidence of emergence delerium in the recovery room. A combination of intravenous ketamine/dexmedetomidine, or ketodex, has been previously shown to reduce emergence delerium in children undergoing adenotonsillectomy. Here, we study its application in strabismus surgery.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
— 至 18 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • ASA I/II children undergoing outpatient strabismus surgery

排除标准

  • anything not meeting the above

研究组 & 干预措施

study

pediatric patients undergoing outpatient strabismus surgery, and receiving ketodex

干预措施: Dexmedetomidine (Drug)

结局指标

主要结局

Pediatric Anesthesia Emergence Delirium scale scores

时间窗: up to 6 hours in recovery room

A low total score would indicate less emergence delirium

次要结局

  • discharge time(up to 24 hours)
  • wong-baker or numeric pain scores, depending on age(up to 6 hours in recovery room)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Khaled Dajani

Assistant Professor

Ochsner Health System

研究点 (1)

Loading locations...

相似试验

KETODEX for Emergence Delirium in Children... | 临床试验